FDA Approves Regeneron's Livsayis, a Quarterly Injection for Myasthenia Gravis
Fact checked by NewsPlainVerified by NewsPlain: confirmed by at least two named sources
Brief
The FDA approved Regeneron's Livsayis (cemdisiran) on Nov. 18 to treat the generalized form of myasthenia…
Keep reading with NewsPlain Premium
Get the full brief, the full story, what's confirmed, what's still unclear, why it matters, and every source.
5 confirmed facts, 1 open question and 2 sources behind this story.